CorMedix Inc (NASDAQ: CRMD) on Monday, soared 6.27% from the previous trading day, before settling in for the closing price of $11.64. Within the past 52 weeks, CRMD’s price has moved between $3.61 and $17.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 29.80% over the past five years. The company achieved an average annual earnings per share of 456.19%. With a float of $72.39 million, this company’s outstanding shares have now reached $74.43 million.
Let’s look at the performance matrix of the company that is accounted for 65 employees. In terms of profitability, gross margin is 95.19%, operating margin of 17.53%, and the pretax margin is 20.81%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CorMedix Inc is 2.75%, while institutional ownership is 32.27%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 456.19% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
CorMedix Inc (CRMD) is currently performing well based on its current performance indicators. A quick ratio of 3.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 1.80 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
CorMedix Inc (NASDAQ: CRMD) saw its 5-day average volume 1.61 million, a negative change from its year-to-date volume of 1.74 million. As of the previous 9 days, the stock’s Stochastic %D was 77.24%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 57.23%, which indicates a significant decrease from 93.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.51 in the past 14 days, which was lower than the 0.59 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.60, while its 200-day Moving Average is $10.64.
